Kisspeptin as a new serum biomarker to discriminate miscarriage from viable intrauterine pregnancy

To validate the ability of serum kisspeptin-54 to discriminate between first-trimester viable pregnancies and miscarriages.

Source: Fertility and Sterility - January 1, 2018 Category: Reproduction Medicine Authors: Chantae Sullivan-Pyke, Daniel J. Haisenleder, Suneeta Senapati, Olivia Nicolais, Esther Eisenberg, Mary D. Sammel, Kurt T. Barnhart Tags: Original article Source Type: research